AVANDIA was developed by GlaxoSmithKline to treat individuals suffering from Type-II diabetes mellitus.  However, studies have linked it to several serious and fatal events and conditions.  In fact, Avandia is associated with a 43% increase in the risk of heart attack. (read more).

          TRASYLOL was designed by Bayer AG to prevent internal bleeding during surgeries.  However, after it was introduced in the market, studies produced some very alarming findings regarding side effects and complications which include kidney failure, stroke, blood clotting, heart failure, and heart attack. (read more).